OrbusNeich

Related Articles

Stents, Drug Eluting

OrbusNeich Files Patent Infringement Actions Against Boston Scientific in Germany and the Netherlands
New Category of Stent Combines Drug Elution With Pro-Healing Genous Technology
Two-Year Follow-up on Genous Stent Trial Shows Positive Outcomes
An Option to Replace Drug-Eluting Stents
100 Percent Neointimal Strut Coverage Reported With New Stent
Thinner, Flexible Bio-Engineered Stent Released
Endothelial Progenitor-Coated Stent Shows Good PCI Safety, Outcomes
Clinical Data Shows Benefit of Endothelial Cell Capture Stent
Cell-Coated Stent as Effective as DES, but Fewer Drugs Are Needed
Stent Reportedly Accelerates Body’s Natural Healing Process
Study Shows OrbusNeich’s Genous R Stent Has Better Outcomes than DES
Bio-Engineered Stent May Be Safe for Acute MI
R Stent May Have Lower MACE Rate than Drug-Eluting Stents
Combo dual stent system

Stents

OrbusNeich Files Patent Infringement Actions Against Boston Scientific in Germany and the Netherlands
New Category of Stent Combines Drug Elution With Pro-Healing Genous Technology
Study Confirms Stent Captures Endothelial Progenitor Cells, Accelerates Re-Endothelialization
Genous Stent is Safe, Effective in Cases Where Prolonged Dual Antiplatelet Therapy is Not Advisable
Newly Published Data Shows Stent’s Effectiveness in Diabetic Patients
U.S. Patent Grants Expanded Protection for EPC Capture Technology
Data Shows New Stent Offers Better Outcomes Over Bare Metal Stents
An Option to Replace Drug-Eluting Stents
100 Percent Neointimal Strut Coverage Reported With New Stent
Thinner, Flexible Bio-Engineered Stent Released
Endothelial Progenitor-Coated Stent Shows Good PCI Safety, Outcomes
Clinical Data Shows Benefit of Endothelial Cell Capture Stent
Avoiding Drugs, Promoting Re-Endothelialization May be Best Solution for Stent Coatings
Study Says Genous Bio-Engineered R Stent is Feasible in Patients Requiring Undeferrable Noncardiac Surgery
Cell-Coated Stent as Effective as DES, but Fewer Drugs Are Needed
Stent Reportedly Accelerates Body’s Natural Healing Process
Study Shows OrbusNeich’s Genous R Stent Has Better Outcomes than DES
Bio-Engineered R Stent Headlines Hong Kong Cardiology Conference
Bio-Engineered Stent May Be Safe for Acute MI
5,000 Patients Enrolled in EPC Stent Registry
Combo dual stent system

Clinical Trial/Study

New Category of Stent Combines Drug Elution With Pro-Healing Genous Technology
Two-Year Follow-up on Genous Stent Trial Shows Positive Outcomes
Study Confirms Stent Captures Endothelial Progenitor Cells, Accelerates Re-Endothelialization
Genous Stent is Safe, Effective in Cases Where Prolonged Dual Antiplatelet Therapy is Not Advisable
Newly Published Data Shows Stent’s Effectiveness in Diabetic Patients
Data Shows New Stent Offers Better Outcomes Over Bare Metal Stents
Endothelial Progenitor-Coated Stent Shows Good PCI Safety, Outcomes
Clinical Data Shows Benefit of Endothelial Cell Capture Stent
Cell-Coated Stent as Effective as DES, but Fewer Drugs Are Needed
Study Shows OrbusNeich’s Genous R Stent Has Better Outcomes than DES

Stents, Bare Metal

Two-Year Follow-up on Genous Stent Trial Shows Positive Outcomes
Newly Published Data Shows Stent’s Effectiveness in Diabetic Patients
Cobalt Chromium Stent Cleared in Europe
Data Shows New Stent Offers Better Outcomes Over Bare Metal Stents
An Option to Replace Drug-Eluting Stents
Thinner, Flexible Bio-Engineered Stent Released
Study Says Genous Bio-Engineered R Stent is Feasible in Patients Requiring Undeferrable Noncardiac Surgery

Optical Coherence Tomography (OCT)

100 Percent Neointimal Strut Coverage Reported With New Stent

Cardiology Products

Cell-Coated Stent as Effective as DES, but Fewer Drugs Are Needed
OrbusNeich Adds Sapphire NC Coronary Dilatation Catheter to Product Line-Up
New Interventional Devices Launched in Europe

General Cardiology

Cell-Coated Stent as Effective as DES, but Fewer Drugs Are Needed
OrbusNeich Adds Sapphire NC Coronary Dilatation Catheter to Product Line-Up

Angiographic Catheter

OrbusNeich Adds Sapphire NC Coronary Dilatation Catheter to Product Line-Up

Catheters

OrbusNeich Adds Sapphire NC Coronary Dilatation Catheter to Product Line-Up
Coronary Dilatation Catheter Scores with Angioplasty
Coronary Dilatation Catheter Scores with CE Mark
1.25-MM PTCA Dilatation Catheter Gets CE Mark
New Interventional Devices Launched in Europe

Balloon Catheter

OrbusNeich Adds Sapphire NC Coronary Dilatation Catheter to Product Line-Up

Cardiovascular Surgery

OrbusNeich Adds Sapphire NC Coronary Dilatation Catheter to Product Line-Up

Stents, Peripheral

New Interventional Devices Launched in Europe

Peripheral Arterial Disease (PAD) Treatment Devices

New Interventional Devices Launched in Europe